Loading
FORT MYERS — A possible change in future government reimbursements for cancer tests caused NeoGenomics shares to fall 14% on Wednesday.
Click here to Subscribe
Click here to Login
Start your day with the top Gulf Coast business news you need to succeed.
Stay updated with a weekly roundup of big deals, market shifts and the people shaping commercial real estate from Tampa Bay to Naples.